4//SEC Filing
CDK ASSOCIATES, L.L.C. 4
Accession 0000919574-18-005198
CIK 0001634432other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 12:28 PM ET
Size
9.6 KB
Accession
0000919574-18-005198
Insider Transaction Report
Form 4
Kovner Bruce
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-08-08$4.93/sh+360,995$1,778,514→ 6,294,829 total
CAXTON CORP
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-08-08$4.93/sh+360,995$1,778,514→ 6,294,829 total
CDK ASSOCIATES, L.L.C.
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-08-08$4.93/sh+360,995$1,778,514→ 6,294,829 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.878 to $5.00 per share, inclusive. The Reporting Persons undertake to provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]These shares represent (a) 5,968,147 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 326,682 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and entities affiliated with such employees and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Strongbridge Biopharma plc
CIK 0001634432
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001576081
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 12:28 PM ET
- Size
- 9.6 KB